ORG 10172 vs. unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke

Completed

Phase N/A Results

Summary of Purpose

To compare the relative safety and efficacy of a low-molecular-weight heparinoid (ORG 10172) with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 October 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Double-blind randomized trial of 87 patients at 7 centers.

Contacts

Not available